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Available online 11 October 2016It has been described that the sensitivity of the Carba NP test may be low in the case of OXA-48-like
carbapenamases and mass spectrometry based methods as well as a colorimetry based method have been de-
scribed as alternatives. We evaluated 84 Enterobacteriaceae isolates including 31 OXA-48-like producing isolates
and 13 isolates that produced either an imipenemase (IMP; n=8), New Delhi metallo-β-lactamase (NDM; n=
3), or Klebsiella pneumoniae carbapenemase (KPC; n=2), as well as 40 carbapenemase negative Enterobacteria-
ceae isolates.We used the Neo-Rapid CARB kit, assessing the results with the unaided eye and compared itwith a
colorimetric approach. Furthermore, we incubated the isolates in growthmediawithmeropenem andmeasured
the remaining meropenem after one and 2 h of incubation, respectively, using liquid chromatography tandem
mass spectrometry (LC-MS/MS). Whilst all carbapenemase producing isolates with the exception of the OXA-
244 producer tested positive for both the Neo-rapid CARB test using the unaided eye or colorimetry, and the
13 isolates producing either IMP, NDM or KPC hydrolysed the meropenem in the media almost completely
after 2 h of incubation, the 31 OXA-48-like producing isolates exhibited very variable hydrolytic activity when
incubated in growth media with meropenem. In our study, the Neo-Rapid CARB test yielded a sensitivity of
98% for both the traditional and the colorimetric approach with a speciﬁcity of 95% and 100% respectively. Our
results indicate that the Neo-Rapid CARB test may have use for the detection of OXA-48 type carbapenemases
and that it may be particularly important to ensure bacterial lysis for the detection of these weaker hydrolysers.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Enterobacteriaceae1. Introduction
In Enterobacteriaceae, carbapenemases are frequently encoded by
genes located on mobile elements that may transfer between bacterial
strains, species or even genera (Goodman et al., 2016). Phenotypic
tests such as the modiﬁed Hodge test or the Carba NP test are used to
evaluate the presence of carbapenemases (Lutgring and Limbago,
2016).
The Carba NP test was ﬁrst published in 2012. It utilises an acid base
indicator (phenol red) to detect the hydrolysis of imipenem by a
carbapenemase (Dortet et al., 2015). Many commercial tests such as
the Rapidec CARBA NP test (bioMérieux, Marcy-l'Étoile, France), the
Rapid CARB screen (Dortet et al., 2015) and its replacement the Neo-try Centre (BZH), Heidelberg,
. This is an open access article underrapid CARB kit (Rosco Diagnostica, Taastrup, Denmark) are now avail-
able for the detection of carbapenemase activity (Casals, 2015).
It has recently been suggested that the solutions of the Carba NP
test may be prepared in advance and stored at−70 °C for up to a year
(Knox et al., 2016). However, the general agreement is that the test
solution needs to be prepared when needed, making its preparation
laborious (Gallagher et al., 2015). Furthermore, using imipenem
for research purposes is not cost-effective, and it may only be econom-
ically viable if powder aliquots of pharmaceutical formulations are
used. However, these formulations contain other ingredients such
as cilastatin (a dehydropeptidase inhibitor blocking the renal metabo-
lism of imipenem) and in case of the intravenous form sodium
hydrogencarbonate which may interfere with the pH reaction. The in-
tramuscular imipenem formulation lacking sodium hydrogencarbonate
may be used instead, however this formulation is not available in all
countries (AbdelGhani et al., 2015).
In a personal communication with Merck Switzerland we were in-
formed that from a manufacturing perspective all ingredients in the
imipenem/cilastatin preparation Tienam could be evenly distributed,
but since the use as a powder for in vitro testing is not the intendedthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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guaranteed.
For these reasons it might be preferable to use a commercial kit in-
stead of an in-house preparation of the Carba NP test.
There is variation in the literature on the reported accuracy of the
Carba NP test to detect carbapenemase activity (Dortet et al., 2015;
Goodman et al., 2016; Hombach et al., 2015; Lutgring and Limbago,
2016; Papagiannitsis et al., 2015). OXA-48 like β-lactamases are weak
hydrolysers of carbapenems conferring only low levels of resistance in
some isolates. This may impede the detection of these carbapenemases,
which may have signiﬁcant implications for treatment and infection
control (Poirel et al., 2012).
Mass spectrometry based methods have previously been described
for the detection of carbapenemases, using Liquid Chromatography-
Tandem Mass Spectrometry (LC-MS/MS) (Kulkarni et al., 2014; Peaper
et al., 2013) and more commonly matrix-assisted laser desorption
time of ﬂight mass spectrometry (MALDI-TOF MS) (Hrabak et al.,
2012; Lutgring and Limbago, 2016). Papagiannitsis and colleagues re-
cently proposed that MALDI-TOF MS may be superior to the Carba NP
test in the detection of OXA-48- type producers, and it has also been in-
dicated that the use of an Elisamicroplate reader may help improve the
sensitivity of colour changes in order to detect OXA-48-like producers
(Papagiannitsis et al., 2015).
Here we investigated 84 bacterial isolates, both carbapenemase pos-
itive and negative. Carbapenemase producing organisms included 31
OXA-48-like producing isolates and 13 isolates that produced other
carbapenemases. Wewere using the Neo-rapid CARB kit as per package
insert and comparing it with a colorimetric approach using amicroplate
reader.We further evaluated the hydrolysis ofmeropenemby these iso-
lates using LC-MS/MS. The two latter approaches did not require
subculturing for disc testing and the duration of test could therefore
be cut down by one day.2. Materials and methods
2.1. Isolates included in the study
Forty four carbapenemase producing and 40 carbapenemase nega-
tive Enterobaceriaceae of the following description were investigated:
The carbapenemase producing isolates included 31 OXA-48-like
producing isolates, eight imipenemase (IMP) producing isolates, three
New Delhi β-lactamase (NDM) producing isolates and two Klebsiella
pneumoniae carbapenemase (KPC) producing isolates (Table 1).
The OXA-48-like producing isolateswere of the following Enterobac-
teriaceae species: Klebsiella pneumoniae (n= 28), Escherichia coli (n=
1), Klebsiella oxytoca (n = 1) and Enterobacter cloacae (n = 1). The
IMP producing isolates consisted of four E. cloacae, two K. pneumoniae
and two E. coli isolates, the NDM producing isolates consisted of two E.
coli isolates and one K. pneumoniae isolate, and the two KPC producing
isolates were E. coli. Resistance testing and carbapenemase screening
had been performed as previously described for the carbapenemase
positive isolates as well as two carbapenemase negative K. pneumoniae
isolates (Kim et al., 2012, Sidjabat et al., 2014, Sidjabat et al., 2015a,
2015b;Wailan et al., 2015a, 2015b; Zowawi et al., 2014). The geograph-
ic regions of origin of the carbapenemase positive isolates are indicated
in Table 1.
Thirty eight Enterobacteriaceae isolates that were resistant to
ertapenem by disc susceptibility testing as interpreted using EUCAST
standard (EUCAST, 2013) were subsequently added to the study.
These isolates had been tested negative for the production of
carbapenemases using the modiﬁed Hodge test with ertapenem,
imipenemandmeropenemdiscs (Genc et al., 2016). Thesewere provid-
ed by two local hospitals and included twenty two E. coli isolates, twelve
K. pneumoniae isolates, three E. cloacae isolates and one Enterobacter
aerogenes isolate.2.2. Sequencing of blaOXA-48-like genes
The blaOXA-48-like genes were further investigated by ampliﬁca-
tion and sequencing with the primer set Pre_Oxa48Aplus (5′-
CAGTATATTGCATTAAGCAAGGG-3′) and Pre_Oxa48B (5′-CACA
CAAATACGCGCTAACC-3′). These were based on primers previously
described (Poirel et al., 2011). The following PCR conditions were ap-
plied: Initial denaturation, 95 °C for 5 min followed by 35 cycles of
denaturation at 95 °C for 30 s, annealing at 50 °C for 30 s and exten-
sion at 70 °C for 1 min. The ﬁnal extension was done for 10 min at
72 °C. Primer synthesis, PCR ampliﬁcation and sequencing was per-
formed by Macrogen, Seoul, Korea.
The sequences were aligned with the DNA Baser (v.3.5.0) and
the sequences were translated making use of the EMBOSS Transeq
tool (http://www.ebi.ac.uk/Tools/st/emboss_transeq/), and blast-
ed against the NCBI Genbank (http://blast.ncbi.nlm.nih.gov/Blast.
cgi) for identiﬁcation.
2.3. Detection of carbapenemases in live bacterial cells using LC-MS
Two McFarland of each bacterial isolate was incubated in 5 ml of
Mueller Hinton broth (Oxoid, Basingstoke, RG24 8PW, UK) with 4 μg/
ml meropenem at 37 °C while shaking for one or 2 h respectively. The
meropenem was subsequently extracted using methanol with 1%
formic acid, and puriﬁed using a Strata X 33 μ Polymeric Reversed
phase cartridge (Phenomenex, Torrance, CA 90501-1430 USA). Samples
were analysed using the QTRAP 5500 System (AB Sciex, Redwood City,
CA, USA) and the MicroLC 200 System (Eksigent, Redwood City, CA,
USA). The 50 μm electrode was used in the TurboV source to improve
the sensitivity.
The following mobile phases were used: The aqueous solvent A
consisted of 5 mM ammonium formate and the organic solvent B
consisted of 99.9% acetonitrile with 0.1% formic acid. A HALO C18 (AB
Sciex, Redwood City, CA, U.S.A.) (2.7 μm 90 Å, 0.5 × 50 mm) column
was used for the separation of compounds, and the following gradient
was applied: Isocratic ﬂow rate of 2% Solvent B for 1 min, 2–20% B for
4 min, 20–90% B for 30 s, isocratic ﬂow at 90% B for 2.5 min, back to
2% B within 2 min. The Flow rate used was 25 uL/min.
The collision energy (CE) and declustering potential (DP) were
optimised making use of the Analyst software 1.6.2, and were 25 V
and 96 V respectively for both meropenem and the internal standard
[2H6]-meropenem, and the following MRM settings were obtained:m/
z 384.1 → 141.0 for meropenem and m/z 390.165 → 146.9 for [2H6]-
meropenem.
Relative quantiﬁcation was performed by peak integration making
use of Analyst 1.6.2, and dividing the peak areas of 100 ng/ml of [2H6]-
meropenem by the peak area of the incubatedmeropenemwith the re-
spective isolate for one and 2 h. The relative peak areas were subse-
quently compared with the relative peak area of the E. coli ATCC
25922 negative control.
2.4. Neo-Rapid CARB kit using colorimetry
Isolates were incubated overnight on Mueller Hinton Agar (Becton
Dickinson, Sparks, USA) and one full 10 μl loop of each isolate was
lysed using 150 μl of the B-PERII Bacterial Protein Extraction Reagent
(Thermo Scientiﬁc, Rockford, IL, USA). The suspension was vortexed
for 1 min and then kept at room temperature shaking for 30 min. Fifty
microliters of each bacterial suspension was added to two tubes with
100 μl of saline, and a Neo-Rapid CARB Imipenem (×2) + Indicator
Diatab (Rosco Diagnostica, Taastrup, Denmark) was added to one and
a Negative Control Diatab was added to the other tube. The tubes con-
taining the tablets were vortexed and incubated for 2 h at 37 °C shaking
at 250 rpm. After incubation, the tubes were centrifuged at 17,000g for
5min and 50 μl of the supernatant was transferred to a Nunclon™ delta
surface 96 well plate (Thermo Scientiﬁc, Roskilde, Denmark).
Table 1
Results of meropenem reduction assay for n = 44 carbapenemase-producing Enterobacteriaceae clinical isolates. Isolates were cultured in Mueller Hinton broth containing 4 μg/ml
meropenem, and concentrations of meropenemwere measured at one hour and two hour time points using liquid chromatography tandemmass spectrometry (LC-MS/MS). Reductions
in meropenem concentrations in cultured isolates were calculated relative to that observed in an E. coli ATCC 25922 control. The experiments were repeated for the OXA-48-like
carbapenemase producers and both results are listed in the table. The isolates 1 and 14 to 44 originated from the Arabian Peninsula (Zowawi et al., 2014), the isolates 2 (Wailan et al.,
2015a, 2015b), 3 and 6–13 (Sidjabat et al., 2015a) were of Australian origin and isolates 4 and 5 originated from the United States of America (Kim et al., 2012).
Isolate Species Geographical Origin Name Carbapenemase Level of meropenem peak area reduction
compared with E. coli ATCC 25922
1 h incubation 2 h incubation
1 K. pneumoniae Arabian Peninsula KPMC-10 KP NDM 5.9 N100
2 E. coli Australia CR694 NDM-5 48 N100
3 E. coli Australia CR53 NDM-4 30 N100
4 E. coli USA YDC 419 KPC-2 71 N100
5 E. coli USA YD 648 KPC-2 57 N100
6 E. coli Australia Ec1 IMP-4 49 N100
7 E. coli Australia CR48 IMP-4 N100 N100
8 E. cloacae Australia CR19 IMP-4 N100 N100
9 E. cloacae Australia CR17 IMP-4 N100 N100
10 E. cloacae Australia CR12 IMP-4 N100 N100
11 K. pneumoniae Australia CR9 IMP-4 92 N100
12 E. cloacae Australia CR11 IMP-4 N100 N100
13 K. pneumoniae Australia CR10 IMP-4 N100 N100
14 K. oxytoca Arabian Peninsula OMN-35 OXA-48 N100; N100 N100; N100
15 E. cloacae Arabian Peninsula OMN-48 OXA-48 N100; N100 N100; N100
16 K. pneumoniae Arabian Peninsula OMN-50 OXA-48 11; 7.6 N100; N100
17 K. pneumoniae Arabian Peninsula SA-002 OXA-48 49; N100 N100; N100
18 K. pneumoniae Arabian Peninsula SA-003 OXA-48 15; 21 N100; 27.8
19 K. pneumoniae Arabian Peninsula SA-014 OXA-48 4.5; 5.3 N100; N100
20 K. pneumoniae Arabian Peninsula SA-020 OXA-48 3.7; 2.7 N100; N100
21 K. pneumoniae Arabian Peninsula SA-021 OXA-48 4.3; 3.1 N100; N100
22 K. pneumoniae Arabian Peninsula SA-027 OXA-48 17; 5.4 N100; N100
23 K. pneumoniae Arabian Peninsula Egy-6 OXA-48 17; 5.0 46; N100
24 K. pneumoniae Arabian Peninsula SA-070 OXA-48 9.0; 47 N100; N100
25 K. pneumoniae Arabian Peninsula SA-039 OXA-48 3.2; 2.1 19; 7.5
26 K. pneumoniae Arabian Peninsula SA-001 OXA-48 0.1; 0.6 1.5; 1.5
27 K. pneumoniae Arabian Peninsula SA-005 OXA-48 0.9; 0.9 3.2; 3.7
28 K. pneumoniae Arabian Peninsula SA-007 OXA-48 1.4; 0.7 2.7; 4.0
29 K. pneumoniae Arabian Peninsula SA-008 OXA-48 1.0; 0.7 3.2; 2.7
30 K. pneumoniae Arabian Peninsula SA-015 OXA-48 0.7; 0.5 1.3; 1.5
31 K. pneumoniae Arabian Peninsula SA-018 OXA-48 0.8; 0.6 1.2; 1.1
32 K. pneumoniae Arabian Peninsula SA-022 OXA-48 1.0; 0.5 1.1; 0.8
33 K. pneumoniae Arabian Peninsula SA-023 OXA-48 1.2; 0.5 2.1; 1.3
34 K. pneumoniae Arabian Peninsula SA-025 OXA-48 1.2; 0.4 1.9; 1.9
35 K. pneumoniae Arabian Peninsula SA-028 OXA-48 2.5; 1.8 6.5; 5.0
36 K. pneumoniae Arabian Peninsula SA-029 OXA-48 1.1; 1.3 2.6; 2.5
37 K. pneumoniae Arabian Peninsula SA-031 OXA-48 1.4; 1.4 4.0; 5.5
38 K. pneumoniae Arabian Peninsula SA-032 OXA-48 1.4; 1.3 2.9; 4.0
39 K. pneumoniae Arabian Peninsula SA-034 OXA-48 1.3; 1.0 1.1; 1.2
40 K. pneumoniae Arabian Peninsula SA-036 OXA-48 1.3; 1.1 1.8; 1.9
41 K. pneumoniae Arabian Peninsula SA-038 OXA-48 1.1; 1.4 1.6; 2.1
42 K. pneumoniae Arabian Peninsula QTR-46 OXA-181 0.2; 1.3 3.0; 2.5
43 K. pneumoniae Arabian Peninsula QTR-35 OXA-232 0.2; 1.0 2.4; 1.9
44 E. coli Arabian Peninsula QTR-23 OXA-244 0.2; 1.8 6.9; 14
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timodemicroplate reader (Tecan Group Ltd. Maennedorf, Switzerland).2.5. Neo-Rapid CARB kit using the unaided eye
The testwas performed as per insert, using ErtapenemAntimicrobial
Susceptibility Test Discs, BBL™ Sensi-Disc™, 10 μg (Becton Dickinson,
Sparks, USA). Stored isolates were cultured overnight using Mueller
Hinton agar plates (Becton Dickinson, Sparks, USA) and the isolates
were subcultured by lawning 0.5 McFarland onto new plates and an
ertapenem disc was added. One full 10 μl loop was suspended in
200 μl B-PER II buffer diluted 1:1 with 0.9% NaCl and the suspension
was vortexed for 1 min and maintained at room temperature for
30 min. Fifty microliters of the suspension were added to two tubes
with 150 μl of 0.9% NaCl, and one Imipenem(×2) + Indicator (CARB)
diatab was added to one tube and the CARB Negative Control Diatab
was added to the other tube. The tubes were vortexed for 1–2 s in
order to disintegrate the tablet. The samples were incubated at 37 °Cand results were read by blinded lab personnel after 15 min, 30 min,
one and 2 h respectively.
3. Results
3.1. Sequencing of blaOXA-48-like genes
Full sequencing of the blaOXA-48-like genes revealed that twenty eight
out of the thirty one isolates carried blaOXA-48, whereas one isolate each
carried blaOXA-181, blaOXA-232 and blaOXA-244, respectively (Table 1).
3.2. Detection of carbapenemases in live bacterial cells using LC-MS/MS
All the 40 carbapenemase negative isolates had their relative peak
area reduced by a factor that ranged between 0.7 and 2.3 compared
with the E. coli ATCC 25922 negative control.
The isolates that produced either NDM, IMP or KPC demonstrated
strong hydrolytic activity. After 1 h of incubation, one NDM positive K.
pneumoniae isolate had meropenem reduced by a factor of six, and the
Fig. 1. Absorbance ratio at 560 nm of the Neo Rapid CARB negative control versus the test
containing imipenem for the 84 isolates investigated in this study (x-axis). The y axis
indicates the number of isolates with the respective absorbance ratios. All
carbapenemase negative isolates had a relative absorbance of either 1.0 or less. The
OXA-244 isolate had a relative absorbance of 0.6 and was therefore considered negative.
The OXA-232 positive isolate had a relative absorbance of 1.1. All other isolates had a
relative absorbance of 1.3 or more.
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or more. All thirteen isolates had meropenem decreased by a factor of
above one hundred after 2 h of incubation (Table 1).
The 31 OXA-48-like producing isolates showed variable degrada-
tion of meropenem in the MHB media culture assay as measured by
LC-MS/MS. This was also the case amongst the 28 isolates that
were producing OXA-48 and not a variant. The experiments for
these 31 Oxa-48-like producing isolates were repeated with results
shown in Table 1.
The blaOXA-244 carrying E. coli isolate showed no detectable hydroly-
sis after 1 h of incubation compared with the carbapenemase negative
isolates. However, the amount of meropenem was reduced by a factor
of seven and fourteen after two hours of incubation in two separate
experiments.
The amount of meropenem was not reduced compared with the E.
coli ATCC 25922 negative control in the OXA-181 producing K.
pneumoniae isolate after one hour of incubation. After two hours of in-
cubation, meropenem was reduced by a factor of two or three respec-
tively, showing very little hydrolysis. For the blaOXA-232 positive K.
pneumoniae isolate, no reduction of meropenem could be detected
after one or two hours of incubation comparedwith the carbapenemase
negative isolates investigated in this study.
One blaOXA-48 positive K. oxytoca, one E. cloacae and one K.
pneumoniae isolate each hydrolysed meropenem almost completely
after one hour already.
In the case of eight blaOXA-48 positive K. pneumoniae isolates,
meropenem was reduced by a factor of three or more compared with
the E. coli ATCC 25922 negative control after one hour of incubation.
After two hours of incubation with these eight isolates, meropenem
was hydrolysed almost completely.
The remaining twenty blaOXA-48 positive K. pneumoniae isolates
showed little or no hydrolysis (Table 1).3.3. Neo-Rapid CARB kit using colorimetry
Using colorimetry, the Neo-Rapid CARB test yielded a sensitivity of
98% and a speciﬁcity of 100%.
Whilst the absorbance at 560 nm was the same or higher for the
imipenem containing test than the control for all carbapenemase nega-
tive isolates, the absorbancewas lower for the imipenemcontaining test
than the control for all but one carbapenemase positive isolate.
When dividing the absorbance of the Neo-Rapid CARB negative con-
trol by the absorbance of the test containing imipenem, all 40
carbapenemase negative isolates had a relative absorbance of one or
less.
Forty-three out of the 44 carbapenemase positive isolates (98%) had
an absorbance which was lower in the sample with imipenem than the
control and had therefore a relative absorbance above one. The excep-
tion was the OXA-244 positive isolate. One OXA-48 positive, one IMP
positive and the OXA-232 positive K. pneumoniae isolate had a relative
absorbance that ranged between 1.1 and 1.5. All other isolates had a rel-
ative absorbance of 1.6 or higher (Fig. 1).3.4. Neo-Rapid CARB kit using the unaided eye
Using the unaided eye and the Neo-Rapid CARB kit as per package
insert, a sensitivity of 98% was obtained, with a speciﬁcity of 95%. The
only carbapenemase producing isolate that gave false negative results
was the OXA-244 producer included in the study. Two carbapenemase
negative isolates were identiﬁed as positive, one of which was an E.
coli isolate which was positive after 15 min and then turned
uninterpretable due to colour change to yellow of the control. The
other was a K. pneumoniae isolate which turned positive after 2 h of
incubation.4. Discussion
We tested 84 Enterobacteriaceae isolates including 40
carbapenemase negative isolates, 31 OXA-48 like producers
(OXA-48; n = 28, OXA-181; n = 1 and OXA-244; n = 1), as well
as 13 isolates producing either IMP (n = 8), NDM (n = 3) and
KPC (n = 1) using the Neo-Rapid CARB test. We compared the
Neo-Rapid CARB test using the unaided eye versus a colorimetric
approach using a multiplate reader to interpret colour change.
We also assessed the reduction in meropenem by incubation of
the isolates in MHB growth media for one or 2 h respectively,
using a LC-MS/MS instrument for quantitation.
We found a speciﬁcity 95% for theNeo-Rapid CARB test using the un-
aided eye and 100% for the colorimetric approach.When incubating the
40 carbapenemase negative isolates in growthmedia withmeropenem,
the amount of remaining meropenem varied between 0.43 and 1.43
times the E. coli ATCC 25922 control after 2 h of incubation.
Previous studies suggested that the CarbaNP testmay have low sen-
sitivity for OXA-48-like producing isolates (Goodman et al., 2016;
Lutgring and Limbago, 2016; Papagiannitsis et al., 2015). However in
our isolate collectionwe identiﬁed 30 out of the 31OXA-48-like produc-
ing isolates by both the Neo-Rapid CARB test interpreted using the un-
aided eye as well as the colorimetric approach. The only exception
was the OXA-244 producing isolate, an OXA-48-type carbapenemase
that had previously been described not to be reliably detected with
the Carba NP test (Dortet et al., 2015, 2016).
Whilst the sensitivity was 98% for the Neo-Rapid CARB test using
both the unaided eye and the colorimetric approach, a very variable hy-
drolytic activity was detected when incubating the isolates in growth
media with meropenem. All 13 isolates that produced either NDM,
IMP or KPC had a remaining amount of meropenem that was b1%
after 2 h of incubation compared with the remaining meropenem of
the E. coli ATCC 25922 negative control. However, this was only the
case for 11 out of the 31 OXA-48-like producers, some of which showed
no increased hydrolytic activity compared with the 40 carbapenemase
negative isolates.
The fact that there was no major issue with detecting OXA-type
carbapenemases with the Carba NP test, where a lysis step is involved,
may indicate that the differences in meropenem degradation in the
presence of live bacterial cells is not due to variability in expression of
the enzyme, but due to additional resistance mechanisms such as
decreased permeability (Poirel et al., 2012). In Gram-negative organ-
isms β-lactamases are located in the bacterial periplasm, and
carbapenemases generally enter Gram-negative bacteria through
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OXA-48 type may need additional resistancemechanisms such as porin
loss in order to confer high levels of carbapenem resistance (Poirel et al.,
2012). Therefore, it may be particularly important to ensure lysis for the
detection of OXA-48-type carbapenemase activity. In our studywewere
adhering to the package insert of the Neo-rapid CARB tests which states
that the bacterial samples need to be vortexed in lysis buffer for 1 min
and leave them at room temperature for an additional 30 min.
It has been suggested that an increased bacterial inoculum may be
needed for the Carba NP test, in order to appropriately detect IMP,
NDM and OXA-48 producers (Gallagher et al., 2015; Hombach et al.,
2015). Here we used a full 10 μl loop and both the colorimetry based
Neo-Rapid CARB test and the traditional test using the unaided eye
had high speciﬁcity and sensitivity.
Whilst the OXA-244 producer included in our study was the only
isolate that tested falsly negative, meropenem degradation was detect-
ed when incubating the isolate in growth media. It has been suggested
that whilst OXA-244 has similar hydrolytic activity as OXA-48 for
ertapenem and meropenem, it hydrolyses imipenem much less efﬁ-
ciently (Potron et al., 2016), and the Neo-Rapid carb test may therefore
not be suitable to detect OXA-244.
5. Conclusions
The traditional and the colorimetric approach of the Neo-Rapid carb
test showed high levels of sensitivity (98% in both cases) and speciﬁcity
(95% for the traditional approach and 100% for the colorimetric ap-
proach). Using colorimetry, the test was performedwithout disc testing
and consequently results would be achieved one day earlier.
OXA-244 producers may not reliably be detected by the Neo-Rapid
CARB test (Dortet et al., 2015, 2016; Potron et al., 2016), and sequencing
of the blaOXA-48-like genes may help detecting this carbapenemase.
Our results using the LC-MS/MS indicate that bacterial lysis
may be particularly important for isolates producing OXA-48-like
carbapenemases, as these are relatively weak carbapenem hydrolysers
and other resistance mechanisms such as porin loss are likely to play a
role (Poirel et al., 2012).
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